nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Pazopanib—kidney cancer	0.116	0.181	CbGbCtD
Gemfibrozil—CYP3A4—Everolimus—kidney cancer	0.0562	0.0875	CbGbCtD
Gemfibrozil—CYP2C8—Pazopanib—kidney cancer	0.0491	0.0765	CbGbCtD
Gemfibrozil—CYP1A2—Pazopanib—kidney cancer	0.038	0.0592	CbGbCtD
Gemfibrozil—CYP3A4—Temsirolimus—kidney cancer	0.0379	0.0591	CbGbCtD
Gemfibrozil—CYP2C9—Capecitabine—kidney cancer	0.0358	0.0557	CbGbCtD
Gemfibrozil—CYP2C8—Erlotinib—kidney cancer	0.0351	0.0546	CbGbCtD
Gemfibrozil—CYP2C8—Paclitaxel—kidney cancer	0.0321	0.05	CbGbCtD
Gemfibrozil—CYP2C8—Sorafenib—kidney cancer	0.0285	0.0444	CbGbCtD
Gemfibrozil—CYP1A2—Erlotinib—kidney cancer	0.0271	0.0423	CbGbCtD
Gemfibrozil—CYP2C19—Sorafenib—kidney cancer	0.0239	0.0373	CbGbCtD
Gemfibrozil—CYP2C9—Paclitaxel—kidney cancer	0.0224	0.0349	CbGbCtD
Gemfibrozil—CYP1A2—Sorafenib—kidney cancer	0.0221	0.0344	CbGbCtD
Gemfibrozil—CYP3A4—Pazopanib—kidney cancer	0.0199	0.031	CbGbCtD
Gemfibrozil—CYP2C9—Sorafenib—kidney cancer	0.0199	0.031	CbGbCtD
Gemfibrozil—CYP3A4—Erlotinib—kidney cancer	0.0142	0.0222	CbGbCtD
Gemfibrozil—CYP3A4—Paclitaxel—kidney cancer	0.013	0.0203	CbGbCtD
Gemfibrozil—CYP3A4—Sorafenib—kidney cancer	0.0116	0.018	CbGbCtD
Gemfibrozil—CYP3A4—Vinblastine—kidney cancer	0.0114	0.0178	CbGbCtD
Gemfibrozil—CYP3A4—Vincristine—kidney cancer	0.0112	0.0175	CbGbCtD
Gemfibrozil—CYP3A4—Sunitinib—kidney cancer	0.00937	0.0146	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—kidney cancer	0.00702	0.0109	CbGbCtD
Gemfibrozil—CYP2C19—urine—kidney cancer	0.00348	0.167	CbGeAlD
Gemfibrozil—CYP1A2—urine—kidney cancer	0.00284	0.136	CbGeAlD
Gemfibrozil—CYP2C9—urine—kidney cancer	0.0027	0.13	CbGeAlD
Gemfibrozil—CYP3A4—urine—kidney cancer	0.00206	0.0988	CbGeAlD
Gemfibrozil—PPARA—renal system—kidney cancer	0.00205	0.0984	CbGeAlD
Gemfibrozil—PPARA—kidney—kidney cancer	0.00198	0.0951	CbGeAlD
Gemfibrozil—SLCO1B1—renal system—kidney cancer	0.00131	0.0627	CbGeAlD
Gemfibrozil—SLCO1B1—kidney—kidney cancer	0.00126	0.0607	CbGeAlD
Gemfibrozil—CYP2C8—renal system—kidney cancer	0.000743	0.0357	CbGeAlD
Gemfibrozil—CYP2C8—kidney—kidney cancer	0.000719	0.0345	CbGeAlD
Gemfibrozil—CYP1A2—renal system—kidney cancer	0.000696	0.0334	CbGeAlD
Gemfibrozil—CYP3A4—renal system—kidney cancer	0.000504	0.0242	CbGeAlD
Gemfibrozil—CYP3A4—kidney—kidney cancer	0.000487	0.0234	CbGeAlD
Gemfibrozil—Urticaria—Sorafenib—kidney cancer	0.000229	0.000821	CcSEcCtD
Gemfibrozil—Photosensitivity—Doxorubicin—kidney cancer	0.000228	0.000818	CcSEcCtD
Gemfibrozil—Diarrhoea—Vinblastine—kidney cancer	0.000228	0.000817	CcSEcCtD
Gemfibrozil—Abdominal pain—Sorafenib—kidney cancer	0.000228	0.000817	CcSEcCtD
Gemfibrozil—Diarrhoea—Everolimus—kidney cancer	0.000227	0.000814	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Sunitinib—kidney cancer	0.000227	0.000813	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Capecitabine—kidney cancer	0.000227	0.000813	CcSEcCtD
Gemfibrozil—Pruritus—Erlotinib—kidney cancer	0.000227	0.000812	CcSEcCtD
Gemfibrozil—Fatigue—Dactinomycin—kidney cancer	0.000226	0.000811	CcSEcCtD
Gemfibrozil—Flatulence—Paclitaxel—kidney cancer	0.000225	0.000806	CcSEcCtD
Gemfibrozil—Pain—Dactinomycin—kidney cancer	0.000224	0.000805	CcSEcCtD
Gemfibrozil—Tension—Paclitaxel—kidney cancer	0.000224	0.000803	CcSEcCtD
Gemfibrozil—Dysgeusia—Paclitaxel—kidney cancer	0.000223	0.000801	CcSEcCtD
Gemfibrozil—Eczema—Doxorubicin—kidney cancer	0.000223	0.0008	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Gemcitabine—kidney cancer	0.000222	0.000797	CcSEcCtD
Gemfibrozil—Oedema—Gemcitabine—kidney cancer	0.000222	0.000797	CcSEcCtD
Gemfibrozil—Nervousness—Paclitaxel—kidney cancer	0.000222	0.000795	CcSEcCtD
Gemfibrozil—Dizziness—Vinblastine—kidney cancer	0.00022	0.00079	CcSEcCtD
Gemfibrozil—Dizziness—Everolimus—kidney cancer	0.000219	0.000787	CcSEcCtD
Gemfibrozil—Abdominal pain—Sunitinib—kidney cancer	0.000219	0.000786	CcSEcCtD
Gemfibrozil—Diarrhoea—Erlotinib—kidney cancer	0.000219	0.000786	CcSEcCtD
Gemfibrozil—Nervous system disorder—Gemcitabine—kidney cancer	0.000218	0.000782	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Gemcitabine—kidney cancer	0.000218	0.000781	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dactinomycin—kidney cancer	0.000216	0.000775	CcSEcCtD
Gemfibrozil—Skin disorder—Gemcitabine—kidney cancer	0.000216	0.000775	CcSEcCtD
Gemfibrozil—Rhinitis—Capecitabine—kidney cancer	0.000216	0.000773	CcSEcCtD
Gemfibrozil—Vision blurred—Paclitaxel—kidney cancer	0.000215	0.000771	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000215	0.000769	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Capecitabine—kidney cancer	0.000214	0.000767	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000214	0.000766	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000212	0.000762	CcSEcCtD
Gemfibrozil—Vomiting—Vinblastine—kidney cancer	0.000212	0.000759	CcSEcCtD
Gemfibrozil—Dizziness—Erlotinib—kidney cancer	0.000212	0.000759	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Capecitabine—kidney cancer	0.000211	0.000758	CcSEcCtD
Gemfibrozil—Vomiting—Everolimus—kidney cancer	0.000211	0.000757	CcSEcCtD
Gemfibrozil—Anaemia—Paclitaxel—kidney cancer	0.000211	0.000756	CcSEcCtD
Gemfibrozil—Paraesthesia—Vincristine—kidney cancer	0.000211	0.000755	CcSEcCtD
Gemfibrozil—Rash—Everolimus—kidney cancer	0.000209	0.00075	CcSEcCtD
Gemfibrozil—Dermatitis—Everolimus—kidney cancer	0.000209	0.00075	CcSEcCtD
Gemfibrozil—Headache—Vinblastine—kidney cancer	0.000209	0.000748	CcSEcCtD
Gemfibrozil—Angioedema—Paclitaxel—kidney cancer	0.000208	0.000748	CcSEcCtD
Gemfibrozil—Headache—Everolimus—kidney cancer	0.000208	0.000745	CcSEcCtD
Gemfibrozil—Abdominal pain—Dactinomycin—kidney cancer	0.000207	0.000744	CcSEcCtD
Gemfibrozil—Asthenia—Sorafenib—kidney cancer	0.000207	0.000741	CcSEcCtD
Gemfibrozil—Vertigo—Paclitaxel—kidney cancer	0.000205	0.000735	CcSEcCtD
Gemfibrozil—Syncope—Paclitaxel—kidney cancer	0.000205	0.000734	CcSEcCtD
Gemfibrozil—Leukopenia—Paclitaxel—kidney cancer	0.000204	0.000732	CcSEcCtD
Gemfibrozil—Pruritus—Sorafenib—kidney cancer	0.000204	0.000731	CcSEcCtD
Gemfibrozil—Vomiting—Erlotinib—kidney cancer	0.000204	0.00073	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000203	0.000727	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Vincristine—kidney cancer	0.000202	0.000726	CcSEcCtD
Gemfibrozil—Fatigue—Vincristine—kidney cancer	0.000202	0.000725	CcSEcCtD
Gemfibrozil—Rash—Erlotinib—kidney cancer	0.000202	0.000724	CcSEcCtD
Gemfibrozil—Dermatitis—Erlotinib—kidney cancer	0.000202	0.000723	CcSEcCtD
Gemfibrozil—Eye disorder—Capecitabine—kidney cancer	0.000201	0.000721	CcSEcCtD
Gemfibrozil—Headache—Erlotinib—kidney cancer	0.000201	0.000719	CcSEcCtD
Gemfibrozil—Loss of consciousness—Paclitaxel—kidney cancer	0.000201	0.000719	CcSEcCtD
Gemfibrozil—Pain—Vincristine—kidney cancer	0.0002	0.000719	CcSEcCtD
Gemfibrozil—Constipation—Vincristine—kidney cancer	0.0002	0.000719	CcSEcCtD
Gemfibrozil—Paraesthesia—Gemcitabine—kidney cancer	0.0002	0.000716	CcSEcCtD
Gemfibrozil—Cough—Paclitaxel—kidney cancer	0.000199	0.000714	CcSEcCtD
Gemfibrozil—Asthenia—Sunitinib—kidney cancer	0.000199	0.000713	CcSEcCtD
Gemfibrozil—Nausea—Vinblastine—kidney cancer	0.000198	0.00071	CcSEcCtD
Gemfibrozil—Somnolence—Gemcitabine—kidney cancer	0.000198	0.000709	CcSEcCtD
Gemfibrozil—Convulsion—Paclitaxel—kidney cancer	0.000198	0.000709	CcSEcCtD
Gemfibrozil—Nausea—Everolimus—kidney cancer	0.000197	0.000707	CcSEcCtD
Gemfibrozil—Diarrhoea—Sorafenib—kidney cancer	0.000197	0.000707	CcSEcCtD
Gemfibrozil—Pruritus—Sunitinib—kidney cancer	0.000196	0.000703	CcSEcCtD
Gemfibrozil—Myalgia—Paclitaxel—kidney cancer	0.000194	0.000697	CcSEcCtD
Gemfibrozil—Chest pain—Paclitaxel—kidney cancer	0.000194	0.000697	CcSEcCtD
Gemfibrozil—Arthralgia—Paclitaxel—kidney cancer	0.000194	0.000697	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Capecitabine—kidney cancer	0.000194	0.000695	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000193	0.000692	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000192	0.000689	CcSEcCtD
Gemfibrozil—Fatigue—Gemcitabine—kidney cancer	0.000192	0.000688	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Vincristine—kidney cancer	0.000192	0.000687	CcSEcCtD
Gemfibrozil—Dizziness—Sorafenib—kidney cancer	0.00019	0.000683	CcSEcCtD
Gemfibrozil—Constipation—Gemcitabine—kidney cancer	0.00019	0.000682	CcSEcCtD
Gemfibrozil—Pain—Gemcitabine—kidney cancer	0.00019	0.000682	CcSEcCtD
Gemfibrozil—Nausea—Erlotinib—kidney cancer	0.00019	0.000682	CcSEcCtD
Gemfibrozil—Alopecia—Capecitabine—kidney cancer	0.00019	0.000682	CcSEcCtD
Gemfibrozil—Diarrhoea—Sunitinib—kidney cancer	0.00019	0.00068	CcSEcCtD
Gemfibrozil—Mental disorder—Capecitabine—kidney cancer	0.000188	0.000676	CcSEcCtD
Gemfibrozil—Asthenia—Dactinomycin—kidney cancer	0.000188	0.000675	CcSEcCtD
Gemfibrozil—Confusional state—Paclitaxel—kidney cancer	0.000188	0.000673	CcSEcCtD
Gemfibrozil—Oedema—Paclitaxel—kidney cancer	0.000186	0.000668	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Paclitaxel—kidney cancer	0.000186	0.000668	CcSEcCtD
Gemfibrozil—Abdominal pain—Vincristine—kidney cancer	0.000185	0.000665	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—kidney cancer	0.000185	0.000663	CcSEcCtD
Gemfibrozil—Flatulence—Capecitabine—kidney cancer	0.000185	0.000662	CcSEcCtD
Gemfibrozil—Dysgeusia—Capecitabine—kidney cancer	0.000183	0.000657	CcSEcCtD
Gemfibrozil—Dizziness—Sunitinib—kidney cancer	0.000183	0.000657	CcSEcCtD
Gemfibrozil—Feeling abnormal—Gemcitabine—kidney cancer	0.000183	0.000657	CcSEcCtD
Gemfibrozil—Shock—Paclitaxel—kidney cancer	0.000183	0.000657	CcSEcCtD
Gemfibrozil—Vomiting—Sorafenib—kidney cancer	0.000183	0.000657	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—kidney cancer	0.000183	0.000656	CcSEcCtD
Gemfibrozil—Nervous system disorder—Paclitaxel—kidney cancer	0.000183	0.000655	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Paclitaxel—kidney cancer	0.000182	0.000654	CcSEcCtD
Gemfibrozil—Rash—Sorafenib—kidney cancer	0.000182	0.000651	CcSEcCtD
Gemfibrozil—Dermatitis—Sorafenib—kidney cancer	0.000181	0.000651	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—kidney cancer	0.000181	0.000649	CcSEcCtD
Gemfibrozil—Skin disorder—Paclitaxel—kidney cancer	0.000181	0.000649	CcSEcCtD
Gemfibrozil—Headache—Sorafenib—kidney cancer	0.00018	0.000647	CcSEcCtD
Gemfibrozil—Diarrhoea—Dactinomycin—kidney cancer	0.00018	0.000644	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Doxorubicin—kidney cancer	0.000179	0.000643	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—kidney cancer	0.000177	0.000634	CcSEcCtD
Gemfibrozil—Vision blurred—Capecitabine—kidney cancer	0.000176	0.000633	CcSEcCtD
Gemfibrozil—Vomiting—Sunitinib—kidney cancer	0.000176	0.000632	CcSEcCtD
Gemfibrozil—Rash—Sunitinib—kidney cancer	0.000175	0.000627	CcSEcCtD
Gemfibrozil—Dermatitis—Sunitinib—kidney cancer	0.000175	0.000626	CcSEcCtD
Gemfibrozil—Headache—Sunitinib—kidney cancer	0.000174	0.000623	CcSEcCtD
Gemfibrozil—Anaemia—Capecitabine—kidney cancer	0.000173	0.000621	CcSEcCtD
Gemfibrozil—Eosinophilia—Doxorubicin—kidney cancer	0.000172	0.000615	CcSEcCtD
Gemfibrozil—Nausea—Sorafenib—kidney cancer	0.000171	0.000614	CcSEcCtD
Gemfibrozil—Pancreatitis—Doxorubicin—kidney cancer	0.00017	0.000609	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00017	0.000608	CcSEcCtD
Gemfibrozil—Vertigo—Capecitabine—kidney cancer	0.000168	0.000603	CcSEcCtD
Gemfibrozil—Asthenia—Vincristine—kidney cancer	0.000168	0.000603	CcSEcCtD
Gemfibrozil—Syncope—Capecitabine—kidney cancer	0.000168	0.000602	CcSEcCtD
Gemfibrozil—Leukopenia—Capecitabine—kidney cancer	0.000168	0.000601	CcSEcCtD
Gemfibrozil—Paraesthesia—Paclitaxel—kidney cancer	0.000167	0.0006	CcSEcCtD
Gemfibrozil—Vomiting—Dactinomycin—kidney cancer	0.000167	0.000598	CcSEcCtD
Gemfibrozil—Somnolence—Paclitaxel—kidney cancer	0.000166	0.000594	CcSEcCtD
Gemfibrozil—Rash—Dactinomycin—kidney cancer	0.000165	0.000593	CcSEcCtD
Gemfibrozil—Nausea—Sunitinib—kidney cancer	0.000165	0.00059	CcSEcCtD
Gemfibrozil—Loss of consciousness—Capecitabine—kidney cancer	0.000165	0.00059	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—kidney cancer	0.000164	0.00059	CcSEcCtD
Gemfibrozil—Dyspepsia—Paclitaxel—kidney cancer	0.000164	0.000588	CcSEcCtD
Gemfibrozil—Cough—Capecitabine—kidney cancer	0.000163	0.000586	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000161	0.000576	CcSEcCtD
Gemfibrozil—Fatigue—Paclitaxel—kidney cancer	0.000161	0.000576	CcSEcCtD
Gemfibrozil—Diarrhoea—Vincristine—kidney cancer	0.00016	0.000575	CcSEcCtD
Gemfibrozil—Asthenia—Gemcitabine—kidney cancer	0.00016	0.000572	CcSEcCtD
Gemfibrozil—Arthralgia—Capecitabine—kidney cancer	0.000159	0.000572	CcSEcCtD
Gemfibrozil—Chest pain—Capecitabine—kidney cancer	0.000159	0.000572	CcSEcCtD
Gemfibrozil—Myalgia—Capecitabine—kidney cancer	0.000159	0.000572	CcSEcCtD
Gemfibrozil—Constipation—Paclitaxel—kidney cancer	0.000159	0.000571	CcSEcCtD
Gemfibrozil—Pain—Paclitaxel—kidney cancer	0.000159	0.000571	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000158	0.000568	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000158	0.000567	CcSEcCtD
Gemfibrozil—Pruritus—Gemcitabine—kidney cancer	0.000157	0.000564	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—kidney cancer	0.000157	0.000562	CcSEcCtD
Gemfibrozil—Nausea—Dactinomycin—kidney cancer	0.000156	0.000559	CcSEcCtD
Gemfibrozil—Dizziness—Vincristine—kidney cancer	0.000155	0.000556	CcSEcCtD
Gemfibrozil—Confusional state—Capecitabine—kidney cancer	0.000154	0.000552	CcSEcCtD
Gemfibrozil—Feeling abnormal—Paclitaxel—kidney cancer	0.000153	0.00055	CcSEcCtD
Gemfibrozil—Oedema—Capecitabine—kidney cancer	0.000153	0.000548	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000152	0.000546	CcSEcCtD
Gemfibrozil—Diarrhoea—Gemcitabine—kidney cancer	0.000152	0.000546	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—kidney cancer	0.000152	0.000544	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000151	0.000543	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—kidney cancer	0.000151	0.00054	CcSEcCtD
Gemfibrozil—Shock—Capecitabine—kidney cancer	0.00015	0.000539	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—kidney cancer	0.00015	0.000538	CcSEcCtD
Gemfibrozil—Nervous system disorder—Capecitabine—kidney cancer	0.00015	0.000537	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Capecitabine—kidney cancer	0.00015	0.000536	CcSEcCtD
Gemfibrozil—Vomiting—Vincristine—kidney cancer	0.000149	0.000534	CcSEcCtD
Gemfibrozil—Skin disorder—Capecitabine—kidney cancer	0.000148	0.000532	CcSEcCtD
Gemfibrozil—Urticaria—Paclitaxel—kidney cancer	0.000148	0.00053	CcSEcCtD
Gemfibrozil—Rash—Vincristine—kidney cancer	0.000148	0.00053	CcSEcCtD
Gemfibrozil—Dermatitis—Vincristine—kidney cancer	0.000148	0.00053	CcSEcCtD
Gemfibrozil—Abdominal pain—Paclitaxel—kidney cancer	0.000147	0.000528	CcSEcCtD
Gemfibrozil—Headache—Vincristine—kidney cancer	0.000147	0.000527	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000146	0.000524	CcSEcCtD
Gemfibrozil—Vomiting—Gemcitabine—kidney cancer	0.000141	0.000507	CcSEcCtD
Gemfibrozil—Rash—Gemcitabine—kidney cancer	0.00014	0.000503	CcSEcCtD
Gemfibrozil—Dermatitis—Gemcitabine—kidney cancer	0.00014	0.000502	CcSEcCtD
Gemfibrozil—Headache—Gemcitabine—kidney cancer	0.000139	0.0005	CcSEcCtD
Gemfibrozil—Nausea—Vincristine—kidney cancer	0.000139	0.000499	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000139	0.000499	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—kidney cancer	0.000139	0.000498	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—kidney cancer	0.000138	0.000495	CcSEcCtD
Gemfibrozil—Paraesthesia—Capecitabine—kidney cancer	0.000137	0.000492	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—kidney cancer	0.000136	0.000489	CcSEcCtD
Gemfibrozil—Dyspepsia—Capecitabine—kidney cancer	0.000135	0.000482	CcSEcCtD
Gemfibrozil—Asthenia—Paclitaxel—kidney cancer	0.000134	0.000479	CcSEcCtD
Gemfibrozil—Nausea—Gemcitabine—kidney cancer	0.000132	0.000474	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000132	0.000473	CcSEcCtD
Gemfibrozil—Fatigue—Capecitabine—kidney cancer	0.000132	0.000472	CcSEcCtD
Gemfibrozil—Pruritus—Paclitaxel—kidney cancer	0.000132	0.000472	CcSEcCtD
Gemfibrozil—Constipation—Capecitabine—kidney cancer	0.000131	0.000469	CcSEcCtD
Gemfibrozil—Pain—Capecitabine—kidney cancer	0.000131	0.000469	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—kidney cancer	0.00013	0.000465	CcSEcCtD
Gemfibrozil—Diarrhoea—Paclitaxel—kidney cancer	0.000127	0.000457	CcSEcCtD
Gemfibrozil—Feeling abnormal—Capecitabine—kidney cancer	0.000126	0.000452	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Capecitabine—kidney cancer	0.000125	0.000448	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—kidney cancer	0.000125	0.000448	CcSEcCtD
Gemfibrozil—Dizziness—Paclitaxel—kidney cancer	0.000123	0.000442	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—kidney cancer	0.000123	0.000439	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—kidney cancer	0.000121	0.000436	CcSEcCtD
Gemfibrozil—Urticaria—Capecitabine—kidney cancer	0.000121	0.000435	CcSEcCtD
Gemfibrozil—Abdominal pain—Capecitabine—kidney cancer	0.000121	0.000433	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—kidney cancer	0.000119	0.000426	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—kidney cancer	0.000118	0.000425	CcSEcCtD
Gemfibrozil—Vomiting—Paclitaxel—kidney cancer	0.000118	0.000425	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—kidney cancer	0.000118	0.000424	CcSEcCtD
Gemfibrozil—Rash—Paclitaxel—kidney cancer	0.000117	0.000421	CcSEcCtD
Gemfibrozil—Dermatitis—Paclitaxel—kidney cancer	0.000117	0.000421	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—kidney cancer	0.000117	0.00042	CcSEcCtD
Gemfibrozil—Headache—Paclitaxel—kidney cancer	0.000117	0.000418	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—kidney cancer	0.000114	0.000408	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—kidney cancer	0.000112	0.0004	CcSEcCtD
Gemfibrozil—Nausea—Paclitaxel—kidney cancer	0.000111	0.000397	CcSEcCtD
Gemfibrozil—Asthenia—Capecitabine—kidney cancer	0.00011	0.000393	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—kidney cancer	0.000108	0.000389	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—kidney cancer	0.000108	0.000388	CcSEcCtD
Gemfibrozil—Pruritus—Capecitabine—kidney cancer	0.000108	0.000388	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—kidney cancer	0.000108	0.000387	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—kidney cancer	0.000106	0.00038	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—kidney cancer	0.000105	0.000378	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—kidney cancer	0.000105	0.000375	CcSEcCtD
Gemfibrozil—Diarrhoea—Capecitabine—kidney cancer	0.000105	0.000375	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—kidney cancer	0.000103	0.000368	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—kidney cancer	0.000103	0.000368	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—kidney cancer	0.000103	0.000368	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000102	0.000366	CcSEcCtD
Gemfibrozil—Dizziness—Capecitabine—kidney cancer	0.000101	0.000362	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—kidney cancer	9.93e-05	0.000356	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—kidney cancer	9.85e-05	0.000353	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—kidney cancer	9.85e-05	0.000353	CcSEcCtD
Gemfibrozil—Vomiting—Capecitabine—kidney cancer	9.72e-05	0.000348	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—kidney cancer	9.69e-05	0.000347	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—kidney cancer	9.66e-05	0.000346	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—kidney cancer	9.64e-05	0.000346	CcSEcCtD
Gemfibrozil—Rash—Capecitabine—kidney cancer	9.63e-05	0.000345	CcSEcCtD
Gemfibrozil—Dermatitis—Capecitabine—kidney cancer	9.63e-05	0.000345	CcSEcCtD
Gemfibrozil—Headache—Capecitabine—kidney cancer	9.57e-05	0.000343	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—kidney cancer	9.57e-05	0.000343	CcSEcCtD
Gemfibrozil—Nausea—Capecitabine—kidney cancer	9.08e-05	0.000325	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.97e-05	0.000322	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—kidney cancer	8.84e-05	0.000317	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—kidney cancer	8.76e-05	0.000314	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—kidney cancer	8.67e-05	0.000311	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.5e-05	0.000305	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—kidney cancer	8.49e-05	0.000305	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—kidney cancer	8.42e-05	0.000302	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—kidney cancer	8.42e-05	0.000302	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—kidney cancer	8.12e-05	0.000291	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—kidney cancer	8.05e-05	0.000289	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—kidney cancer	7.83e-05	0.000281	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—kidney cancer	7.79e-05	0.000279	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—kidney cancer	7.07e-05	0.000253	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—kidney cancer	6.97e-05	0.00025	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—kidney cancer	6.74e-05	0.000242	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—kidney cancer	6.51e-05	0.000234	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—kidney cancer	6.26e-05	0.000225	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—kidney cancer	6.21e-05	0.000223	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—kidney cancer	6.2e-05	0.000222	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—kidney cancer	6.17e-05	0.000221	CcSEcCtD
Gemfibrozil—Nausea—Doxorubicin—kidney cancer	5.85e-05	0.00021	CcSEcCtD
Gemfibrozil—CYP2C19—Metabolism—CCBL1—kidney cancer	3.43e-05	0.000589	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—VEGFA—kidney cancer	3.39e-05	0.000583	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.37e-05	0.000579	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.36e-05	0.000577	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ACY1—kidney cancer	3.34e-05	0.000574	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.34e-05	0.000573	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GLIPR1—kidney cancer	3.33e-05	0.000573	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPAT—kidney cancer	3.33e-05	0.000573	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PDHB—kidney cancer	3.33e-05	0.000572	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.32e-05	0.000571	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—MYC—kidney cancer	3.32e-05	0.00057	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—POMC—kidney cancer	3.32e-05	0.00057	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTP1—kidney cancer	3.31e-05	0.000568	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.29e-05	0.000565	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.26e-05	0.00056	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MAPK3—kidney cancer	3.21e-05	0.000552	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CRABP1—kidney cancer	3.18e-05	0.000546	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ABCB1—kidney cancer	3.13e-05	0.000538	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CCBL1—kidney cancer	3.13e-05	0.000537	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.1e-05	0.000533	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APRT—kidney cancer	3.1e-05	0.000532	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—FH—kidney cancer	3.1e-05	0.000532	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.09e-05	0.000532	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MAPK1—kidney cancer	3.05e-05	0.000525	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.05e-05	0.000524	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTM1—kidney cancer	3.04e-05	0.000522	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.03e-05	0.00052	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPAT—kidney cancer	2.97e-05	0.000511	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.97e-05	0.000511	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ITPR2—kidney cancer	2.95e-05	0.000508	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.94e-05	0.000505	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.93e-05	0.000504	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GPC3—kidney cancer	2.91e-05	0.0005	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.91e-05	0.000499	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.89e-05	0.000497	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—KRAS—kidney cancer	2.89e-05	0.000496	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP1A1—kidney cancer	2.88e-05	0.000495	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.85e-05	0.00049	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PDHB—kidney cancer	2.84e-05	0.000488	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—POMC—kidney cancer	2.83e-05	0.000487	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CA2—kidney cancer	2.83e-05	0.000487	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.83e-05	0.000486	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—FH—kidney cancer	2.76e-05	0.000475	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APRT—kidney cancer	2.76e-05	0.000475	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALAD—kidney cancer	2.76e-05	0.000474	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.72e-05	0.000468	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPAT—kidney cancer	2.71e-05	0.000466	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.71e-05	0.000466	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.7e-05	0.000464	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ST3GAL2—kidney cancer	2.69e-05	0.000463	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ACHE—kidney cancer	2.69e-05	0.000463	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTT1—kidney cancer	2.69e-05	0.000463	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.68e-05	0.00046	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CCBL1—kidney cancer	2.67e-05	0.000459	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.65e-05	0.000455	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.63e-05	0.000453	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GPC3—kidney cancer	2.6e-05	0.000447	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ACY1—kidney cancer	2.58e-05	0.000443	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SCARB1—kidney cancer	2.55e-05	0.000438	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CA2—kidney cancer	2.53e-05	0.000435	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PGK1—kidney cancer	2.52e-05	0.000434	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC5A3—kidney cancer	2.52e-05	0.000434	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS1—kidney cancer	2.52e-05	0.000434	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APRT—kidney cancer	2.52e-05	0.000433	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—FH—kidney cancer	2.52e-05	0.000433	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—LDHB—kidney cancer	2.48e-05	0.000425	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PSMD7—kidney cancer	2.47e-05	0.000425	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALAD—kidney cancer	2.46e-05	0.000423	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.46e-05	0.000423	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.42e-05	0.000415	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.4e-05	0.000413	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GPC3—kidney cancer	2.37e-05	0.000407	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.37e-05	0.000407	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.35e-05	0.000404	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—BCHE—kidney cancer	2.35e-05	0.000403	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SLC5A5—kidney cancer	2.32e-05	0.000398	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPAT—kidney cancer	2.32e-05	0.000398	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.32e-05	0.000398	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CA2—kidney cancer	2.31e-05	0.000396	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.29e-05	0.000393	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.26e-05	0.000389	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.25e-05	0.000387	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PGK1—kidney cancer	2.25e-05	0.000387	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALAD—kidney cancer	2.25e-05	0.000386	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SLC2A1—kidney cancer	2.24e-05	0.000385	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—LDHB—kidney cancer	2.21e-05	0.00038	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PDHB—kidney cancer	2.19e-05	0.000377	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.19e-05	0.000377	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—POMC—kidney cancer	2.19e-05	0.000376	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.17e-05	0.000373	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—FH—kidney cancer	2.15e-05	0.00037	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APRT—kidney cancer	2.15e-05	0.00037	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—POMC—kidney cancer	2.15e-05	0.000369	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CA9—kidney cancer	2.15e-05	0.000369	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.14e-05	0.000368	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.13e-05	0.000367	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.11e-05	0.000362	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.1e-05	0.000361	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CCBL1—kidney cancer	2.06e-05	0.000354	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PGK1—kidney cancer	2.05e-05	0.000353	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.05e-05	0.000353	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GPC3—kidney cancer	2.03e-05	0.000348	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—LDHB—kidney cancer	2.02e-05	0.000346	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CA2—kidney cancer	1.97e-05	0.000339	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALAD—kidney cancer	1.92e-05	0.00033	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CA9—kidney cancer	1.92e-05	0.000329	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.89e-05	0.000325	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.87e-05	0.000322	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.87e-05	0.000322	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.87e-05	0.000321	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.83e-05	0.000315	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CRABP1—kidney cancer	1.83e-05	0.000314	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.79e-05	0.000307	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPAT—kidney cancer	1.79e-05	0.000307	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.77e-05	0.000304	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.76e-05	0.000302	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PGK1—kidney cancer	1.76e-05	0.000302	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CA9—kidney cancer	1.75e-05	0.0003	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LDHB—kidney cancer	1.72e-05	0.000296	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTM1—kidney cancer	1.72e-05	0.000295	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTGS2—kidney cancer	1.71e-05	0.000294	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.71e-05	0.000293	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ITPR2—kidney cancer	1.7e-05	0.000292	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APRT—kidney cancer	1.66e-05	0.000286	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—FH—kidney cancer	1.66e-05	0.000286	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MAPK3—kidney cancer	1.64e-05	0.000282	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CRABP1—kidney cancer	1.63e-05	0.00028	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP1A1—kidney cancer	1.63e-05	0.000279	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—kidney cancer	1.6e-05	0.000274	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.56e-05	0.000269	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPC3—kidney cancer	1.56e-05	0.000269	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ACHE—kidney cancer	1.55e-05	0.000266	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTT1—kidney cancer	1.55e-05	0.000266	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA2—kidney cancer	1.52e-05	0.000261	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ITPR2—kidney cancer	1.51e-05	0.00026	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTEN—kidney cancer	1.49e-05	0.000257	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CA9—kidney cancer	1.49e-05	0.000257	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CRABP1—kidney cancer	1.49e-05	0.000255	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALAD—kidney cancer	1.48e-05	0.000255	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SCARB1—kidney cancer	1.46e-05	0.000252	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.46e-05	0.000251	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS1—kidney cancer	1.45e-05	0.000249	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.45e-05	0.000249	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PSMD7—kidney cancer	1.42e-05	0.000244	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.41e-05	0.000243	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.4e-05	0.00024	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTT1—kidney cancer	1.38e-05	0.000237	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ACHE—kidney cancer	1.38e-05	0.000237	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ITPR2—kidney cancer	1.38e-05	0.000237	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PGK1—kidney cancer	1.36e-05	0.000233	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.36e-05	0.000233	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—BCHE—kidney cancer	1.35e-05	0.000232	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.34e-05	0.00023	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.33e-05	0.000229	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LDHB—kidney cancer	1.33e-05	0.000228	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SCARB1—kidney cancer	1.31e-05	0.000225	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS1—kidney cancer	1.29e-05	0.000222	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.29e-05	0.000221	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.27e-05	0.000219	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CRABP1—kidney cancer	1.27e-05	0.000218	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PSMD7—kidney cancer	1.27e-05	0.000218	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTT1—kidney cancer	1.26e-05	0.000216	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ACHE—kidney cancer	1.26e-05	0.000216	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.25e-05	0.000214	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—POMC—kidney cancer	1.21e-05	0.000208	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—BCHE—kidney cancer	1.2e-05	0.000207	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SCARB1—kidney cancer	1.19e-05	0.000205	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.19e-05	0.000204	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ITPR2—kidney cancer	1.18e-05	0.000203	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS1—kidney cancer	1.18e-05	0.000203	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PSMD7—kidney cancer	1.16e-05	0.000199	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA9—kidney cancer	1.15e-05	0.000198	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.15e-05	0.000197	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.11e-05	0.000191	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—BCHE—kidney cancer	1.1e-05	0.000189	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.09e-05	0.000187	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.09e-05	0.000187	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.08e-05	0.000186	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTT1—kidney cancer	1.08e-05	0.000185	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ACHE—kidney cancer	1.08e-05	0.000185	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTP1—kidney cancer	1.07e-05	0.000184	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CA—kidney cancer	1.05e-05	0.000181	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.05e-05	0.00018	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SCARB1—kidney cancer	1.02e-05	0.000175	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.02e-05	0.000175	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ABCB1—kidney cancer	1.02e-05	0.000174	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS1—kidney cancer	1.01e-05	0.000173	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PSMD7—kidney cancer	9.89e-06	0.00017	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—kidney cancer	9.86e-06	0.000169	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CRABP1—kidney cancer	9.8e-06	0.000168	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.71e-06	0.000167	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—kidney cancer	9.67e-06	0.000166	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTP1—kidney cancer	9.57e-06	0.000165	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—BCHE—kidney cancer	9.38e-06	0.000161	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1A1—kidney cancer	9.34e-06	0.000161	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC5A5—kidney cancer	9.26e-06	0.000159	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ITPR2—kidney cancer	9.11e-06	0.000157	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ABCB1—kidney cancer	9.06e-06	0.000156	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC2A1—kidney cancer	8.94e-06	0.000154	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.86e-06	0.000152	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—kidney cancer	8.8e-06	0.000151	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTP1—kidney cancer	8.73e-06	0.00015	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.68e-06	0.000149	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTEN—kidney cancer	8.43e-06	0.000145	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1A1—kidney cancer	8.34e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTT1—kidney cancer	8.31e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ACHE—kidney cancer	8.31e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCB1—kidney cancer	8.26e-06	0.000142	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—kidney cancer	8.02e-06	0.000138	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SCARB1—kidney cancer	7.86e-06	0.000135	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS1—kidney cancer	7.78e-06	0.000134	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.68e-06	0.000132	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PSMD7—kidney cancer	7.63e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1A1—kidney cancer	7.61e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.57e-06	0.00013	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTP1—kidney cancer	7.46e-06	0.000128	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—BCHE—kidney cancer	7.24e-06	0.000124	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.15e-06	0.000123	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCB1—kidney cancer	7.06e-06	0.000121	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—POMC—kidney cancer	6.97e-06	0.00012	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.9e-06	0.000119	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—kidney cancer	6.86e-06	0.000118	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.85e-06	0.000118	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.5e-06	0.000112	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.25e-06	0.000107	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—POMC—kidney cancer	6.22e-06	0.000107	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CA—kidney cancer	5.95e-06	0.000102	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTP1—kidney cancer	5.76e-06	9.89e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—POMC—kidney cancer	5.67e-06	9.74e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—kidney cancer	5.56e-06	9.55e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCB1—kidney cancer	5.45e-06	9.37e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.34e-06	9.18e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—kidney cancer	5.29e-06	9.09e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.02e-06	8.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—kidney cancer	4.96e-06	8.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTEN—kidney cancer	4.85e-06	8.33e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—POMC—kidney cancer	4.85e-06	8.33e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—kidney cancer	4.52e-06	7.77e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTEN—kidney cancer	4.33e-06	7.43e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTEN—kidney cancer	3.94e-06	6.78e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—kidney cancer	3.86e-06	6.64e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—POMC—kidney cancer	3.74e-06	6.43e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.42e-06	5.88e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTEN—kidney cancer	3.37e-06	5.79e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.05e-06	5.24e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—kidney cancer	2.98e-06	5.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.78e-06	4.78e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTEN—kidney cancer	2.6e-06	4.47e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.38e-06	4.09e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.84e-06	3.15e-05	CbGpPWpGaD
